Eton Pharmaceuticals (ETON) Short Interest Ratio & Short Volume → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free ETON Stock Alerts $3.09 +0.03 (+0.98%) (As of 12:58 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Eton Pharmaceuticals Short Interest DataCurrent Short Volume220,400 sharesPrevious Short Volume242,900 sharesChange Vs. Previous Month-9.26%Dollar Volume Sold Short$826,500.00Short Interest Ratio / Days to Cover3.1Last Record DateMarch 31, 2024Outstanding Shares25,690,000 sharesFloat Size22,430,000 sharesShort Percent of Float0.98%Today's Trading Volume20,335 sharesAverage Trading Volume68,630 sharesToday's Volume Vs. Average30% Short Selling Eton Pharmaceuticals ? Sign up to receive the latest short interest report for Eton Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatETON Short Interest Over TimeETON Days to Cover Over TimeETON Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Eton Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024220,400 shares $826,500.00 -9.3%1.0%3.1 $3.75 3/15/2024242,900 shares $935,165.00 +6.9%1.1%3.2 $3.85 2/29/2024227,200 shares $1.01 million -38.0%1.0%3.2 $4.45 2/15/2024366,200 shares $1.68 million -4.6%1.6%5.3 $4.59 1/31/2024384,000 shares $1.79 million +0.7%1.7%4.6 $4.67 1/15/2024381,200 shares $1.67 million -14.5%1.7%4.5 $4.37 Get the Latest News and Ratings for ETON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eton Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023445,800 shares $1.95 million +22.5%2.0%5.1 $4.38 12/15/2023363,800 shares $1.62 million -41.4%1.6%3.8 $4.45 11/30/2023620,900 shares $2.20 million -17.6%2.8%4.9 $3.54 11/15/2023753,600 shares $2.78 million -21.1%3.4%4.7 $3.69 10/31/2023954,600 shares $4.03 million -5.5%4.3%2.1 $4.22 10/15/20231,010,000 shares $3.96 million +3.0%4.5%2.2 $3.92 9/30/2023980,700 shares $4.09 million +3.6%4.4%2.1 $4.17 9/15/2023946,700 shares $4.69 million -1.2%4.2%2.1 $4.95 8/31/2023958,600 shares $4.31 million -27.4%4.3%2.3 $4.50 8/15/20231,320,000 shares $6.26 million +150.1%5.9%3.5 $4.74 7/31/2023527,700 shares $1.49 million -6.2%2.4%9.6 $2.82 7/15/2023562,700 shares $1.67 million +3.8%2.5%11.5 $2.97 6/30/2023542,100 shares $1.89 million -1.8%2.4%11.8 $3.49 6/15/2023552,000 shares $2.02 million -1.9%2.5%12 $3.66 5/31/2023562,700 shares $2.23 million +6.1%2.5%11.4 $3.96 5/15/2023530,400 shares $1.88 million -9.7%2.4%11.1 $3.54 4/30/2023587,500 shares $2.13 million +7.4%2.7%12.1 $3.63 4/15/2023547,200 shares $1.93 million +6.9%2.5%9.4 $3.52 3/31/2023511,700 shares $1.97 million -1.3%2.3%7.7 $3.85 3/15/2023518,300 shares $1.97 million +11.0%2.4%7.7 $3.80 2/28/2023467,100 shares $1.74 million +5.5%2.1%7.2 $3.73 2/15/2023442,600 shares $1.54 million -5.8%2.0%6.6 $3.49 1/31/2023469,900 shares $1.64 million -14.1%2.1%6.3 $3.48 1/15/2023547,100 shares $1.91 million -10.9%2.5%7 $3.50 12/30/2022614,100 shares $1.73 million +16.0%2.8%8.9 $2.82 12/15/2022529,200 shares $1.72 million -6.4%2.4%7.4 $3.25 11/30/2022565,500 shares $1.71 million -13.7%2.6%8.8 $3.02 11/15/2022655,000 shares $2.01 million -1.4%3.0%10.1 $3.07 10/31/2022664,000 shares $1.69 million +1.2%3.0%9 $2.55 10/15/2022655,900 shares $1.43 million -6.5%3.0%9.9 $2.18 9/30/2022701,400 shares $1.47 million -1.6%3.2%3.9 $2.10 9/15/2022712,500 shares $1.56 million -1.7%3.2%3.7 $2.19 8/31/2022724,500 shares $1.64 million -12.2%3.3%3.8 $2.26 8/15/2022824,700 shares $2.21 million -9.9%4.0%4.1 $2.68Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here ETON Short Interest - Frequently Asked Questions What is Eton Pharmaceuticals' current short interest? Short interest is the volume of Eton Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 220,400 shares of ETON short. 0.98% of Eton Pharmaceuticals' shares are currently sold short. Learn More on Eton Pharmaceuticals' current short interest. What is a good short interest ratio for Eton Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ETON shares currently have a short interest ratio of 3.0. Learn More on Eton Pharmaceuticals's short interest ratio. Which institutional investors are shorting Eton Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eton Pharmaceuticals: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Eton Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.98% of Eton Pharmaceuticals' floating shares are currently sold short. Is Eton Pharmaceuticals' short interest increasing or decreasing? Eton Pharmaceuticals saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 220,400 shares, a decline of 9.3% from the previous total of 242,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Eton Pharmaceuticals' float size? Eton Pharmaceuticals currently has issued a total of 25,690,000 shares. Some of Eton Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eton Pharmaceuticals currently has a public float of 22,430,000 shares. How does Eton Pharmaceuticals' short interest compare to its competitors? 0.98% of Eton Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Eton Pharmaceuticals: BioXcel Therapeutics, Inc. (10.54%), Chimerix, Inc. (1.56%), PMV Pharmaceuticals, Inc. (6.40%), Oncolytics Biotech Inc. (1.23%), Affimed (1.51%), Assembly Biosciences, Inc. (1.17%), Hookipa Pharma Inc (0.45%), YS Biopharma Co., Ltd. (0.54%), Spero Therapeutics, Inc. (1.21%), Clearside Biomedical, Inc. (0.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Eton Pharmaceuticals stock? Short selling ETON is an investing strategy that aims to generate trading profit from Eton Pharmaceuticals as its price is falling. ETON shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Eton Pharmaceuticals? A short squeeze for Eton Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ETON, which in turn drives the price of the stock up even further. How often is Eton Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ETON, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: BioXcel Therapeutics Short Interest Chimerix Short Interest PMV Pharmaceuticals Short Interest Oncolytics Biotech Short Interest Affimed Short Interest Assembly Biosciences Short Interest Hookipa Pharma Short Interest YS Biopharma Short Interest Spero Therapeutics Short Interest Clearside Biomedical Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ETON) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden’s $374B Giveaway Into This SectorDTIThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesSHOCKING Crypto Leak…Crypto 101 MediaHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends